๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Hematologic Disorders

Registry of the German CLL Study Group NCT02863692n/a1 site๐Ÿ“ Dresden German CLL Study Group ELVN-001 for the Treatment of Chronic Myeloid Leukemia With and Without T315I Mutation in Japanese Participants NCT06787144Phase 14 sites๐Ÿ“ Akita๐Ÿ“ Sapporo๐Ÿ“ Suita-shi Enliven Therapeutics ยท Tests: ELVN-001 A Clinical Study to Assess Sutacimig in Participants With Congenital Factor VII Deficiency NCT07347249Phase 21 site๐Ÿ“ London Hemab ApS ยท Tests: Sutacimig, Sutacimig Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents NCT05442216Phase 27 sites๐Ÿ“ Miami๐Ÿ“ Orlando๐Ÿ“ Buffalo Joshua Zeidner ยท Tests: Tagraxofusp, Azacitidine, Venetoclax Sickle-cell Disease Registry of the GPOH NCT03327428n/a1 site๐Ÿ“ Heidelberg University Hospital Heidelberg Whole Genome Sequencing (ChromoSeqยฎ) for Acute Lymphoblastic Leukemia (ALL) Patients NCT07313592n/a1 site๐Ÿ“ St Louis Washington University School of Medicine Characterization of T-cell Repertoire in Patients With Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant NCT03921047n/a1 site๐Ÿ“ Los Angeles University of Southern California ยท Tests: Biospecimen Collection, Laboratory Biomarker Analysis A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML NCT05735184Phase 144 sites๐Ÿ“ Phoenix๐Ÿ“ La Jolla๐Ÿ“ Los Angeles Kura Oncology, Inc. ยท Tests: Ziftomenib, Venetoclax, Azacitidine, Daunorubicin, Cytarabine A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma NCT07284758Phase 260 sites๐Ÿ“ Huntsville๐Ÿ“ Phoenix๐Ÿ“ Scottsdale C4 Therapeutics, Inc. ยท Tests: Cemsidomide, Dexamethasone An Observational Study to Learn More About How Well Damoctocog Alfa Pegol Works in Previously Treated Children With Hemophilia A NCT07088458n/a12 sites๐Ÿ“ Loma Linda๐Ÿ“ New Brunswick๐Ÿ“ Many Locations Bayer ยท Tests: Damoctocog alfa pegol (Jivi, Bay94-9027) Evaluation of the Safety and Efficacy of Hemophilia A Gene Therapy Drugs NCT06111638Phase 2, Phase 310 sites๐Ÿ“ Beijing๐Ÿ“ Guangzhou๐Ÿ“ Guiyang Shanghai Xinzhi BioMed Co., Ltd. ยท Tests: Single dose intravenous injection of BBM-H803 Effect of Fish Oil on Hyperlipidemia and Toxicities in Children and Young Adults With Acute Lymphoblastic Leukemia NCT04209244NA4 sites๐Ÿ“ Aalborg๐Ÿ“ Aarhus๐Ÿ“ Copenhagen Copenhagen University Hospital, Rigshospitalet ยท Tests: Eskimo-3 Pure Fish Oil, Rapeseed Oil Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance NCT06483100Phase 21 site๐Ÿ“ St Louis Washington University School of Medicine ยท Tests: Elrantamab, clonoSEQ Peking University Birth Cohort in Weifang (PKUBC-WF) NCT06234332n/a1 site๐Ÿ“ Beijing Peking University ยท Tests: No Interventions TGRX-1942 Chinese Phase I for Advanced Solid Tumor And/or Relapsed/Refractory Hematologic Malignancies NCT06484816Phase 11 site๐Ÿ“ Hangzhou Shenzhen TargetRx Co., Ltd. ยท Tests: TGRX-1942 Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma NCT05896228Phase 21 site๐Ÿ“ Miami Benjamin T Diamond, MD ยท Tests: Iberdomide, Carfilzomib, Daratumumab, Dexamethasone, Acetaminophen A Study to Evaluate Efficacy, Safety, and PK of XEMBIFYยฎ+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma NCT05645107Phase 362 sites๐Ÿ“ Bullhead City๐Ÿ“ Huntington Park๐Ÿ“ St. Petersburg Grifols Therapeutics LLC ยท Tests: Xembify, Placebo Treatment of Newly Diagnosed High Risk Pediatric Acute Lymphoblastic Leukemia NCT06184009Phase 29 sites๐Ÿ“ Seoul๐Ÿ“ Seoul๐Ÿ“ Incheon Jae Wook Lee ยท Tests: ALL, High risk In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET NCT05093335EARLY Phase 11 site๐Ÿ“ New York Memorial Sloan Kettering Cancer Center ยท Tests: [68Ga]-Pentixafor PI3K Inhibitors for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas NCT06530550Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: PI3K inhibitor BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases NCT06794008Phase 21 site๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: BCMA-CD19 CAR-T therapy A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies NCT07195916Phase 122 sites๐Ÿ“ Duarte๐Ÿ“ La Jolla๐Ÿ“ Ann Arbor Incyte Corporation ยท Tests: INCA036873 Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia NCT06429449Phase 11 site๐Ÿ“ Aurora University of Colorado, Denver ยท Tests: Venetoclax, Azacitidine, Mitoxantrone CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL NCT06559189Phase 11 site๐Ÿ“ Aurora University of Colorado, Denver ยท Tests: CD19x22 CAR T Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site๐Ÿ“ Sioux Falls Sanford Health A Personalized Neoantigen Cancer Vaccine in Treatment Naรฏve, Asymptomatic Patients With IGHV Unmutated CLL. NCT03219450Phase 11 site๐Ÿ“ Boston Dana-Farber Cancer Institute ยท Tests: NeoVax, Cyclophosphamide, Pembrolizumab A Phase Ib Study of APG-115 Single Agent or in Combination With Azacitidine or Cytarabine in Patients With AML and MDS. NCT04275518Phase 114 sites๐Ÿ“ Beijing๐Ÿ“ Guangzhou๐Ÿ“ Guangzhou Ascentage Pharma Group Inc. ยท Tests: APG-115, Azacitidine, Cytarabine CAR T-cell Therapy Targeting CD19 and BCMA in Patients with AIHA Who Have Failed โ‰ฅ3 Lines of Therapy. NCT06733610Phase 11 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: universal allogeneic anti-CD19/BCMA CAR T-cells Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors NCT02508038Phase 11 site๐Ÿ“ Madison University of Wisconsin, Madison ยท Tests: TCRฮฑฮฒ+/CD19+ depleted Haploidentical HSCT, Zoledronate Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL) NCT04301076Phase 119 sites๐Ÿ“ Atlanta๐Ÿ“ Atlanta๐Ÿ“ City of Saint Peters National Cancer Institute (NCI) ยท Tests: Biospecimen Collection, Bone Marrow Biopsy, Computed Tomography, Cyclophosphamide, Doxorubicin Hydrochloride
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy